Skip to main content Back to Top
Advertisement

5/9/2022

Ethambutol Tablets

Products Affected - Description

    • Ethambutol tablet, Teva, 400 mg, 100 count, NDC 00555-0923-02 - discontinued

Reason for the Shortage

    • Lupin has ethambutol tablets available.
    • STI Pharma has ethambutol tablets available.
    • Teva discontinued ethambutol tablets in September 2020.
    • X-Gen has Myambutol tablets available.

Available Products

    • Myambutol tablet, X-Gen, 400 mg, 100 count, NDC 68850-0012-01
    • Myambutol tablet, X-Gen, 400 mg, 100 count, NDC 68850-0012-02
    • Ethambutol tablet, Lupin, 100 mg, 100 count, NDC 68180-0280-01
    • Ethambutol tablet, Lupin, 400 mg, 100 count, NDC 68180-0281-01
    • Ethambutol tablet, STI Pharma, 100 mg, 100 count, NDC 54879-0001-01
    • Ethambutol tablet, STI Pharma, 400 mg, 100 count, NDC 54879-0002-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated May 9, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 10, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT